Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Myelofibrosis
Hematologic Oncology Update
by Neil Love, MD
1w ago
Dr Aaron T Gerds from the Cleveland Clinic Taussig Cancer Institute in Cleveland, Ohio, discusses recent updates on available and novel treatment strategies for myelofibrosis ..read more
Visit website
Oncology Today with Dr Neil Love: Key Presentations on Lymphoma from Recent Major Conferences
Hematologic Oncology Update
by Neil Love, MD
1M ago
Dr Andrew D Zelenetz from Memorial Sloan Kettering Cancer Center in New York City discusses recent updates on available and emerging treatment strategies for various lymphomas ..read more
Visit website
Oncology Today with Dr Neil Love: Recent Advances in the Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Hematologic Oncology Update
by Neil Love, MD
1M ago
Dr Elias Jabbour from the University of Texas MD Anderson Cancer Center in Houston discusses recent advances in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia ..read more
Visit website
Oncology Today with Dr Neil Love: Bispecific Antibodies in the Management of Multiple Myeloma
Hematologic Oncology Update
by Neil Love, MD
1M ago
Dr Joshua Richter from the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai in New York, New York, discusses the role of bispecific antibodies in multiple myeloma ..read more
Visit website
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Acute Myeloid Leukemia
Hematologic Oncology Update
by Neil Love, MD
2M ago
Drs Naval Daver and Courtney D DiNardo, both from The University of Texas MD Anderson Cancer Center in Houston, summarize the clinical progress in diagnosing and treating acute myeloid leukemia over the past year, as well as practical considerations for patients with the disease ..read more
Visit website
Meet The Professor: Optimizing the Management of Myelofibrosis — Part 2 of a 2-Part Series
Hematologic Oncology Update
by Neil Love, MD
2M ago
Dr Ruben A Mesa from Wake Forest University School of Medicine in Winston-Salem, North Carolina, discusses recent updates on available and novel treatment strategies for myelofibrosis ..read more
Visit website
Striving for Consensus: Current and Future Management of Paroxysmal Nocturnal Hemoglobinuria
Hematologic Oncology Update
by Neil Love, MD
2M ago
Dr Carlos de Castro, Prof Alexander Röth and Dr Ilene Weitz summarize the biology of paroxysmal nocturnal hemoglobinuria, current treatment approaches, and practical considerations for patients with the disease ..read more
Visit website
Oncology Today with Dr Neil Love: Key Presentations on Myeloproliferative Neoplasms from Recent Major Conferences
Hematologic Oncology Update
by Neil Love, MD
2M ago
Dr Naveen Pemmaraju from The University of Texas MD Anderson Cancer Center in Houston discusses updated findings from ASH 2023 on management approaches for myelofibrosis and polycythemia vera ..read more
Visit website
Oncology Today with Dr Neil Love: Key Presentations on Chronic Lymphocytic Leukemia from Recent Major Conferences
Hematologic Oncology Update
by Neil Love, MD
3M ago
Dr Bita Fakhri from Stanford University in Stanford, California, discusses recent updates from ASH 2023 for the management of chronic lymphocytic leukemia and Richter’s syndrome ..read more
Visit website
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Lymphoma
Hematologic Oncology Update
by Neil Love, MD
3M ago
Dr Andrew M Evens from the Rutgers Cancer Institute of New Jersey in New Brunswick and Dr Sonali M Smith from the University of Chicago in Illinois discuss clinical decision-making with numerous treatment strategies for lymphoma ..read more
Visit website

Follow Hematologic Oncology Update on FeedSpot

Continue with Google
Continue with Apple
OR